Chapter 086. Breast Cancer (Part 13)

Follow-Up of Breast Cancer Patients Despite the availability of sophisticated and expensive imaging techniques and a wide range of serum tumor marker tests, survival is not influenced by early diagnosis of relapse. Surveillance guidelines are given in Table 86-5.Table 86-5 Breast Cancer Surveillance GuidelinesTestFrequencyRecommendedHistory; eliciting symptoms; physical examinationq3–6 months x 3 years; q6–12 months x 2 years; then annuallyBreast self-examinationMonthlyMammographyAnnuallyPelvic examinationAnnuallyPatienteducationaboutOngoingsymptoms of recurrenceCoordination of careOngoingNot RecommendedComplete blood countSerum chemistry studiesChest radiographsBone scansUltrasound examination of the liverComputed tomography of chest, abdomen, or pelvis ...
Nội dung trích xuất từ tài liệu:
Chapter 086. Breast Cancer (Part 13) Chapter 086. Breast Cancer (Part 13) Follow-Up of Breast Cancer Patients Despite the availability of sophisticated and expensive imaging techniquesand a wide range of serum tumor marker tests, survival is not influenced by earlydiagnosis of relapse. Surveillance guidelines are given in Table 86-5. Table 86-5 Breast Cancer Surveillance Guidelines Test Frequency Recommended History; eliciting symptoms; q3–6 months x 3 years; q6–12physical examination months x 2 years; then annually Breast self-examination Monthly Mammography Annually Pelvic examination Annually Patient education about Ongoingsymptoms of recurrence Coordination of care Ongoing Not Recommended Complete blood count Serum chemistry studies Chest radiographs Bone scans Ultrasound examination of the liver Computed tomography of chest, abdomen, or pelvis Tumor marker CA 15-3, CA 27-29 Tumor marker CEA Source: Recommended Breast Cancer Surveillance Guidelines, ASCOEducation Book, Fall, 1997. Further Readings Breast International Group (BIG) 1-98 Collaborative Group: A comparisonof letrozole and tamoxifen in postmenopausal women with early breast cancer. NEngl J Med 353:2747, 2005 Citron ML et al: Randomized trial of dose-dense versus conventionallyscheduled and sequential versus concurrent combination chemotherapy aspostoperative adjuvant treatment of node-positive primary breast cancer: Firstreport of intergroup trial C9741/cancer and leukemia group B trial 9741. J ClinOncol 21:1431, 2003 [PMID: 12668651] Cleator S et al: Triple-negative breast cancer: Therapeutic options. LancetOncol 8:235, 2007 [PMID: 17329194] Early Breast Cancer Trialists Collaborative Group: Effects ofchemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687, 2005 ———: Effects of radiotherapy and of differences in the extent of surgeryfor early breast cancer on local recurrence and 15-year survival: An overview ofthe randomised trials. Lancet 366:2087, 2005 Giordano S et al: Breast cancer in men. Ann Intern Med 137:678, 2002[PMID: 12379069] Ingle JN et al: Fulvestrant in women with advanced breast cancer afterprogression on prior aromatase inhibitor therapy: North central cancer treatmentgroup trial N0032. J Clin Oncol 24:1052, 2006 [PMID: 16505423] Jakesz R et al: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen:Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455, 2005[PMID: 16084253] Partridge A, Schapira L: Pregnancy and breast cancer. Oncology 19:693,2005 [PMID: 15971447] Romond EH et al: Trastuzumab plus adjuvant chemotherapy for operableHER2-positive breast cancer. N Engl J Med 353:1673, 2005 [PMID: 16236738] Santen RJ, Mansel R: Benign breast disorders. N Engl J Med 353:275,2005 [PMID: 16034013] Shapiro CL, Winer EL (eds): Late effects of treatment and survivorshipissues in early-stage breast cancer. Sem Oncol 30:729, 2003 Bibliography Berry DA: Benefits and risks of screening mammography for women intheir forties: A statistical appraisal. J Natl Cancer Inst 90:1431, 1998 [PMID:9776408] Braun S et al: A pooled analysis of bone marrow micrometastasis in breastcancer. N Engl J Med 353:793, 2005 [PMID: 16120859] Fyles AW et al: Tamoxifen with or without breast irradiation in women 50years of age or older with early breast cancer. N Engl J Med 351:963, 2004[PMID: 15342804] Harris J et al (eds): Diseases of the Breast. 3d ed. Philadelphia, Lippincott-Raven, 2004 Jones SE et al: Randomized phase III study of docetaxel compared withpaclitaxel in metastatic breast cancer. J Clin Oncol 23:5542, 2005 [PMID:16110015] Kendall A et al: Caution: Vaginal estradiol appears to be contraindicated inpostmenopausal women on adjuvant aromatase inhibitors. Annals Oncol 17:584,2006 [PMID: 16443612] Morrow M et al: Preoperative evaluation of abnormal mammographicfindings to avoid unnecessary breast biopsies. Arch Surg 129:1091, 1994 [PMID:7944941] Oh DS et al: Estrogen-regulated genes predict survival in hormonereceptor-positive breast cancers. J Clin Oncol 24:1656, 2006 [PMID: 16505416] Piccart-Gebhart M et al: Trastuzumab after adjuvant chemotherapy inHER2-po ...